There is no product in the shopping cart, buy it!
Jump to Section
Glycosylation is a crucial post-translational modification impacting the structure, function, and biological activity of various biomolecules, including proteins, lipids, peptides, nucleic acids and small molecules like flavonoids and cannabinoids. For instance:
Fig.1 Beneficial glycosylated plant metabolites for humans.1
This process creates complex glycoconjugates like glycoproteins, glycolipids, and glycopeptides. Analyzing these molecules is challenging due to their diverse sugar compositions, linkage types, and structural arrangements. Accurately characterizing glycosylation requires specialized expertise to understand structural variations, identify modification sites, and quantify interactions between glycans and proteins. At Creative Biolabs, we offer specialized glycoconjugate analysis services designed to tackle these complexities. We recognize that each type of biomolecule needs a specific approach to fully understand its glycosylation patterns. Whether you're working with N-glycosylated therapeutic proteins, O-glycosylated cell surface receptors, or glycolipids involved in cell signaling, our comprehensive services utilize advanced technologies to provide precise, useful data. By combining our expertise in molecular diversity with analytical excellence, we empower researchers and biotech partners to navigate the complex field of glycoconjugates, accelerating breakthroughs in glycobiology, disease research, and the development of therapeutics.
Glycosylation is a complex post-translational modification that requires careful, specialized techniques to analyze. The variety of glycan structures and glycoprotein differences make this challenging. To understand glycosylation fully, we use a mix of methods. Each method offers unique insights into different aspects, such as glycan composition or modification sites. At Creative Biolabs, our specialized glycoconjugate analysis services combine these techniques to deliver accurate, detailed results for your research needs.
MS is a key tool for glycosylation analysis. It offers high sensitivity and accuracy, essential for studying complex glycans. These methods provide both qualitative and quantitative data, helping identify glycan types, modification sites, and protein interactions.
Enzymes play a key role in releasing and modifying glycans for analysis. They allow specific cleavage of glycosylation sites, separating glycans from protein backbones.
Lectin arrays are used to study glycan-protein interactions in glycosylated quercetin and alpha glycosyl isoquercitrin, uncovering their binding specificities to immune receptors or microbial lectins. This is invaluable for optimizing drug-targeting strategies. The high-throughput tool study glycan-protein interactions by immobilizing glycans on a solid surface. Our glycobiology microarray services help uncover glycan-binding specificities for the development of novel biomarkers or therapeutics.
Automated systems process hundreds of samples quickly, integrating techniques like HILIC-MS and glycan microarrays.
Advanced computational tools and databases predict glycosylation sites and structures using molecular modeling. We use complement experimental methods to offer a complete view of glycosylation's role in cells and disease. Our team combines computational predictions with wet-lab analysis for robust, multi-faceted glycoconjugate characterization.
Glycosylation, the enzymatic attachment of sugar molecules to proteins, lipids, and other biomolecules, is a fundamental process in cellular biology. Aberrant glycosylation patterns have been linked to diverse pathological conditions, with specific glycoconjugates playing critical roles in disease progression, diagnosis, and therapy. Below is a disease-specific analysis of glycoconjugates.
| Disease | Glycoconjugate Type | Case/Application | Significance |
|---|---|---|---|
| Cancer | Sialylated Glycoproteins (e.g., CA19-9) | CA19-9, a sialylated mucin-type glycoprotein, as a biomarker for pancreatic cancer | Sialylation masks tumor antigens, promoting immune evasion. Targeting sialic acid residues in cancer immunotherapy. |
| Glycolipids (e.g., Globo H) | Globo H in ovarian and breast cancers, under investigation in a vaccine (GM2-KLH) for tumor targeting | Glycolipids like Globo H promote tumor adhesion and metastasis, with vaccine-based cancer treatments being explored. | |
| Autoimmune Diseases | Glycosylated Autoantibodies (e.g., IgG) | In rheumatoid arthritis, altered IgG glycosylation with reduced galactosylation and increased fucosylation | Altered IgG glycosylation correlates with disease severity. Potential for glycoengineered antibodies as therapy. |
| Glycosylated Cytokines (e.g., IL-6) | O-glycosylation of IL-6 in systemic lupus erythematosus (SLE) enhances leukocyte infiltration | Glycosylation of cytokines influences immune responses, with IL-6 glycosylation inhibition as a potential treatment. | |
| Infectious Diseases | Viral Glycoproteins (e.g., Influenza HA) | Influenza hemagglutinin (HA) glycosylation facilitates viral entry, targeted by oseltamivir | Glycosylation of viral glycoproteins helps evade immune detection, and targeted antivirals (e.g., oseltamivir) control infection. |
| Bacterial Lipopolysaccharides (LPS) | LPS in Gram-negative bacteria triggers sepsis, neutralized by polymyxin B | LPS glycosylation affects bacterial virulence, with antibiotics or TLR4 antagonists mitigating sepsis and infections. | |
| Emerging Glycobiology | Glycosylated RNA (GlycoRNA) | Small RNAs modified with N-glycans, bound to Siglec receptors on cell surfaces | Discovery of glycoRNAs as glycan-modified RNAs offers new insight into glycan-protein interactions, impacting immune responses. |
| Know More ↓ | |||
Glycosylation plays a crucial role in a wide variety of biological processes and is integral to the development and efficacy of many biopharmaceuticals. Our specialized glycoconjugate analysis service offers the expertise and advanced tools necessary to navigate the complexities of glycosylation, ensuring that your research is built on the most reliable data available. Whether you're studying disease mechanisms, developing new therapeutics, or optimizing glycoprotein-based drugs, Creative Biolabs is your trusted partner in glycoscience.
References